Evaluation of the Performance of Self-monitoring Optimized by Therapeutic Education in the Recurrence of Wet Age-related Macular Degeneration (AMD)

Overview

Monocentric and prospective study, evaluating the benefit of self-monitoring optimized by therapeutic education either by the environmental Amsler or the Amsler grid according to the patient's choice and to determine the patient's ability to determine the reality itself recidivism and therefore the need for treatment.

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: July 10, 2021

Clinical Trial Outcome Measures

Primary Measures

  • Sensitivity and specificity of self-monitoring by the environmental Amsler or the clinical Amsler grid according to the choice of the patient after therapeutic education.
    • Time Frame: Through study completion, on average of 1 year
    • Sensitivity and specificity of self-monitoring by the environmental Amsler or the clinical Amsler grid according to the choice of the patient after therapeutic education.

Participating in This Clinical Trial

Inclusion Criteria

  • Affiliation to a social security scheme – Patient agreeing to participate in the process of therapeutic education. – Centrofoveal fixation with visual acuity> 2/10 – Antecedent of at least one recurrence so that the patient is aware of the notion of recurrent chronic disease – Intravitreal injection antecedent less than 6 months ago Exclusion Criteria:

  • Vulnerable people – Majors subject to legal protection or unable to express their consent – Arterial emboli disorders of less than three months such as myocardial infarction, stroke

Gender Eligibility: All

Minimum Age: 50 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Clinique Beau Soleil
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Contact(s)
    • Sandy Lacombe, 0467459397, s.lacombe@languedoc-mutualite.fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.